Literature DB >> 21726629

Phosphorylation of Y372 is critical for Jak2 tyrosine kinase activation.

Jacqueline Sayyah1, Kavitha Gnanasambandan, Sushama Kamarajugadda, Shigeharu Tsuda, Jennifer Caldwell-Busby, Peter P Sayeski.   

Abstract

Jak2 tyrosine kinase plays an important role in cytokine mediated signal transduction. There are 49 tyrosine residues in Jak2 and phosphorylation of some of these are known to play important roles in the regulation of Jak2 kinase activity. Here, using mass spectrometry, we identified tyrosine residues Y372 and Y373 as novel sites of Jak2 phosphorylation. Mutation of Y372 to F (Y372F) significantly inhibited Jak2 phosphorylation, including that of Y1007, whereas the Jak2-Y373F mutant displayed only modest reduction in phosphorylation. Relative to Jak2-WT, the ability of Jak2-Y372F to bind to and phosphorylate STAT1 was decreased, resulting in reduced Jak2-mediated downstream gene transcription. While the Y372F mutation had no effect on receptor-independent, hydrogen peroxide-mediated Jak2 activation, it impaired interferon-gamma (IFNγ) and epidermal growth factor (EGF)-dependent Jak2 activation. Interestingly however, the Y372F mutant exhibited normal receptor binding properties. Finally, co-expression of SH2-Bβ only partially restored the activation of the Jak2-Y372F mutant suggesting that the mechanism whereby phosphorylation of Y372 is important for Jak2 activation is via dimerization. As such, our results indicate that Y372 plays a critical yet differential role in Jak2 activation and function via a mechanism involving Jak2 dimerization and stabilization of the active conformation.
Copyright © 2011 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21726629      PMCID: PMC3156348          DOI: 10.1016/j.cellsig.2011.06.015

Source DB:  PubMed          Journal:  Cell Signal        ISSN: 0898-6568            Impact factor:   4.315


  44 in total

1.  A region encompassing the FERM domain of Jak1 is necessary for binding to the cytokine receptor gp130.

Authors:  C M Hilkens; H Is'harc; B F Lillemeier; B Strobl; P A Bates; I Behrmann; I M Kerr
Journal:  FEBS Lett       Date:  2001-09-07       Impact factor: 4.124

2.  Unexpected effects of FERM domain mutations on catalytic activity of Jak3: structural implication for Janus kinases.

Authors:  Y J Zhou; M Chen; N A Cusack; L H Kimmel; K S Magnuson; J G Boyd; W Lin; J L Roberts; A Lengi; R H Buckley; R L Geahlen; F Candotti; M Gadina; P S Changelian; J J O'Shea
Journal:  Mol Cell       Date:  2001-11       Impact factor: 17.970

3.  Autoinhibition of Jak2 tyrosine kinase is dependent on specific regions in its pseudokinase domain.

Authors:  Pipsa Saharinen; Mauno Vihinen; Olli Silvennoinen
Journal:  Mol Biol Cell       Date:  2003-04       Impact factor: 4.138

4.  Reactive oxygen species regulate heat-shock protein 70 via the JAK/STAT pathway.

Authors:  N R Madamanchi; S Li; C Patterson; M S Runge
Journal:  Arterioscler Thromb Vasc Biol       Date:  2001-03       Impact factor: 8.311

5.  The N-terminal domain of Janus kinase 2 is required for Golgi processing and cell surface expression of erythropoietin receptor.

Authors:  L J Huang; S N Constantinescu; H F Lodish
Journal:  Mol Cell       Date:  2001-12       Impact factor: 17.970

6.  Prediction of the structure of human Janus kinase 2 (JAK2) comprising the two carboxy-terminal domains reveals a mechanism for autoregulation.

Authors:  K Lindauer; T Loerting; K R Liedl; R T Kroemer
Journal:  Protein Eng       Date:  2001-01

7.  Novel signal transduction pathway for luteinizing hormone and its interaction with insulin: activation of Janus kinase/signal transducer and activator of transcription and phosphoinositol 3-kinase/Akt pathways.

Authors:  Carla R O Carvalho; José B C Carvalheira; Maria H M Lima; Suzana F Zimmerman; Luciana C Caperuto; Angélica Amanso; Alessandra L Gasparetti; Vainer Meneghetti; Leonardo F Zimmerman; Licio A Velloso; Mario J A Saad
Journal:  Endocrinology       Date:  2003-02       Impact factor: 4.736

Review 8.  JAK redux: a second look at the regulation and role of JAKs in the heart.

Authors:  Mazen Kurdi; George W Booz
Journal:  Am J Physiol Heart Circ Physiol       Date:  2009-08-28       Impact factor: 4.733

9.  Complex effects of naturally occurring mutations in the JAK3 pseudokinase domain: evidence for interactions between the kinase and pseudokinase domains.

Authors:  M Chen; A Cheng; F Candotti; Y J Zhou; A Hymel; A Fasth; L D Notarangelo; J J O'Shea
Journal:  Mol Cell Biol       Date:  2000-02       Impact factor: 4.272

Review 10.  Janus kinases and signal transducers and activators of transcription: their roles in cytokine signaling, development and immunoregulation.

Authors:  R A Ortmann; T Cheng; R Visconti; D M Frucht; J J O'Shea
Journal:  Arthritis Res       Date:  1999-12-23
View more
  1 in total

1.  Tyrosine 201 is required for constitutive activation of JAK2V617F and efficient induction of myeloproliferative disease in mice.

Authors:  Dongqing Yan; Robert E Hutchison; Golam Mohi
Journal:  Blood       Date:  2012-07-26       Impact factor: 22.113

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.